Log on / register
Feedback | Support | My details
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Bégin LR, Offit K, Foulkes WD
Breast Cancer Res 2004, 6:R8-R17
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia
Budroni M, Cesaraccio R, Coviello V, Sechi O, Pirino D, Cossu A, Tanda F, Pisano M, Palomba G, Palmieri G
BMC Cancer 2009, 9:62 (20 February 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

2.


Research article    
Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
Litwiniuk MM, Ronowski K, Filas V, Godlewski DD, Stawicka M, Kaleta R, Brborowicz J
BMC Cancer 2008, 8:100 (13 April 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

3.


Research article    
Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer
Crawford NPS, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW
Breast Cancer Research 2006, 8:R16 (21 March 2006)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

4.


Opinion    
Molecular tumor profiling: translating genomic insights into clinical advances
Trainer AH
Genome Biology 2004, 5:113 (15 July 2004)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]


This article is also cited by a further 8 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.